Human type-1 VDAC, a cisplatin target involved in either apoptotic pathway.
Thinnes
Friedrich P
FP
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D002945:Cisplatin / Q000494:pharmacology*; D006801:Humans; D050995:Voltage-Dependent Anion Channel 1 / Q000096:biosynthesis*
D000970:Antineoplastic Agents; C494762:VDAC1 protein, human; D050995:Voltage-Dependent Anion Channel 1; D002945:Cisplatin